Analysts think RAPT stock price could increase by 65%
Sep 12, 2025, 11:26 AM
69.96%
What does RAPT do
Rapt Therapeutics, based in South San Francisco, specializes in developing oral small molecule therapies for oncology and inflammatory diseases, with key candidates targeting CCR4. The company went public on October 31, 2019, and employs 126 people.
9 analysts think RAPT stock price will increase by 65.35%. The current median analyst target is $26.01 compared to a current stock price of $15.73. The lowest analysts target is $9.09 and the highest analyst target is $39.90.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.